A Calcium Channel Blocker for ME/CFS and Fibromyalgia? Nimodipine Pt. II
- Condition
- ME/CFS
- At worst
- Moderate (mostly housebound)
- Ill for
- Not stated
- Published
- Jun 2019
Summary
Nimodipine, a dihydropyridine calcium channel blocker, caused a severe adverse reaction in this patient after just two tablets, one per day. Illness duration before the trial is not stated. She experienced paralysis in her arms and legs, which reversed only after she stopped the drug. No symptom benefit of any kind is reported, and there is no indication she attempted nimodipine again after the reaction.
What they credit
Credits Calcium channel blockers (nimodipine, amlodipine, verapamil), Nimodipine / tadalafil / vasoactive.
Similar stories
-
the best treatments I've found
Shanti1 credits this vasodilator/oxygen combination with improving brain circulation and says episodes of feeling oxygen-starved, once frequent, are now rare, describing sustained improvement "over time as underlying conditions addressed." No specific doses…
-
Nimodipine use in M.E./CFS - a comprehensive guide (S. Parker, MBA, BSc, January 2014)
Nimodipine, titrated from 45mg up to 90mg daily taken as 30mg three times a day, took her from 20-25% of well to 80-90% of well with mental clarity nearing 90%. She had been ill since 1991 and began the drug in 2006, holding the gain for more than seven…
-
NIMODIPINE use in M.E. / CFS : A comprehensive guide. S. Parker (MBA, BSc) January 2014
Amlodipine, a dihydropyridine calcium channel blocker, was taken for about a month by this ME/CFS patient in Australia. Illness duration before starting is not stated. Her POTS-type symptoms had started improving by the one-month mark. The post is written…
-
NIMODIPINE use in M.E. / CFS : A comprehensive guide. S. Parker (MBA, BSc) January 2014
Nimodipine, a dihydropyridine calcium channel blocker, gave this ME/CFS patient a "noticeable cognitive benefit" at an unspecified dose. Illness duration before starting is not stated. In a later update to the same thread, posted in 2021, they reported that…